Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 2,4-diamino-5-(3,4-dimethoxybenzyl)pyrimidine
2. Diaveridine Monohydrochloride
3. Egis-5645
1. 5355-16-8
2. Diaveridin
3. 2,4-diamino-5-veratrylpyrimidine
4. Diaveridinum
5. Diaveridina
6. 5-(3,4-dimethoxybenzyl)pyrimidine-2,4-diamine
7. Bw 49-210
8. 5-[(3,4-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine
9. Egis-5645
10. 2,4-diamino-5-(3,4-dimethoxybenzyl)pyrimidine
11. 5-((3,4-dimethoxyphenyl)methyl)-2,4-pyrimidinediamine
12. Ai3-23935
13. Pyrimidine, 2,4-diamino-5-veratryl-
14. Nsc-408735
15. Chebi:123115
16. 2,4-pyrimidinediamine, 5-[(3,4-dimethoxyphenyl)methyl]-
17. 5-(3,4-dimethoxy-benzyl)-pyrimidine-2,4-diamine
18. Chembl19633
19. 7kvx81xa87
20. Nsc408735
21. 2,4-pyrimidinediamine, 5-((3,4-dimethoxyphenyl)methyl)-
22. Ncgc00160517-01
23. Bw-49210
24. Diaveridine 10 Microg/ml In Acetonitrile
25. Bw-49-210
26. Dsstox_cid_26200
27. Dsstox_rid_81431
28. Dsstox_gsid_46200
29. Diaveridinum [inn-latin]
30. Diaveridina [inn-spanish]
31. Cas-5355-16-8
32. Diaveridine [usan:inn:ban]
33. Ccris 3784
34. Egis 5645
35. Einecs 226-333-3
36. 5-(3,4-dimethoxybenzyl)-2,4-pyrimidinediamine
37. Nsc 408735
38. Brn 0258464
39. Unii-7kvx81xa87
40. Mfcd00057349
41. Diaveridine [mi]
42. Diaveridine [inn]
43. Diaveridine (usan/inn)
44. Diaveridine [usan]
45. Epitope Id:119685
46. Diaveridine [mart.]
47. Schembl93896
48. Diaveridine [usp-rs]
49. 2,4-diamino-5-(3',4'-dimethoxybenzyl)pyrimidine
50. 5-25-13-00391 (beilstein Handbook Reference)
51. Mls004712092
52. 2,4-dimethoxybenzyl)pyrimidine
53. Ccris-3784
54. Dtxsid2046200
55. Zinc24946
56. Pyrimidine,4-diamino-5-veratryl-
57. Hms3264i16
58. Pharmakon1600-01502300
59. Hy-b1902
60. Tox21_111866
61. Bbl009897
62. Bdbm50138691
63. Nsc759634
64. S5200
65. Stk711076
66. Akos005530708
67. Tox21_111866_1
68. Ccg-213021
69. Nsc-759634
70. 2, 5-[(3,4-dimethoxyphenyl)methyl]-
71. Ncgc00160517-02
72. Ncgc00160517-03
73. Ac-12110
74. As-56306
75. Bw 49210
76. Smr002529995
77. Diaveridine 100 Microg/ml In Acetonitrile
78. Cs-0013961
79. Ft-0603089
80. 210u49
81. D03771
82. D81857
83. Ab01562957_01
84. Diaveridine, Vetranal(tm), Analytical Standard
85. 355d168
86. 5-(3,4-dimethoxybenzyl)-2,4-pyrimidinediamine #
87. A829660
88. Sr-01000939849
89. 2,4-diamino-5-(3',4'-dimethoxybenzyl) Pyrimidine
90. 2,4-diamino-5-(3',4'-dimethoxybenzyl)-pyrimidine
91. Diaveridine, Analytical Standard, >=99.0% (tlc)
92. Sr-01000939849-2
93. W-105726
94. Q27212503
95. Diaveridine, United States Pharmacopeia (usp) Reference Standard
96. Kup
| Molecular Weight | 260.29 g/mol |
|---|---|
| Molecular Formula | C13H16N4O2 |
| XLogP3 | 1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | 260.12732577 g/mol |
| Monoisotopic Mass | 260.12732577 g/mol |
| Topological Polar Surface Area | 96.3 Ų |
| Heavy Atom Count | 19 |
| Formal Charge | 0 |
| Complexity | 279 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
17
PharmaCompass offers a list of Diaveridine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diaveridine manufacturer or Diaveridine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diaveridine manufacturer or Diaveridine supplier.
PharmaCompass also assists you with knowing the Diaveridine API Price utilized in the formulation of products. Diaveridine API Price is not always fixed or binding as the Diaveridine Price is obtained through a variety of data sources. The Diaveridine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Diaveridine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diaveridine, including repackagers and relabelers. The FDA regulates Diaveridine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diaveridine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Diaveridine supplier is an individual or a company that provides Diaveridine active pharmaceutical ingredient (API) or Diaveridine finished formulations upon request. The Diaveridine suppliers may include Diaveridine API manufacturers, exporters, distributors and traders.
Diaveridine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diaveridine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Diaveridine GMP manufacturer or Diaveridine GMP API supplier for your needs.
A Diaveridine CoA (Certificate of Analysis) is a formal document that attests to Diaveridine's compliance with Diaveridine specifications and serves as a tool for batch-level quality control.
Diaveridine CoA mostly includes findings from lab analyses of a specific batch. For each Diaveridine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diaveridine may be tested according to a variety of international standards, such as European Pharmacopoeia (Diaveridine EP), Diaveridine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diaveridine USP).
